In another set of data, Peron et al. [27] presented the significant association of various T cell counts (CD3, CD4, and CD8) observed prior to initiation of chemotherapy with survival in lymphoma, breast cancer, and sarcoma. The gene discussed is CD4; the disease is breast carcinoma.